HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
- Citation:
- J Clin Oncol JCO2301507
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 3259
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- BMS (now Lilly), Genentech, Pfizer, Sanofi
- Grants:
- U10CA180821, U10CA180882; UG1CA233253, UG1CA233180, UG1CA233337, UG1CA233373; U10CA180888, UG1CA180830 (SWOG).
- Corr. Author:
- Authors:
- Francesca Battaglin Fang-Shu Ou Xueping Qu Howard S Hochster Donna Niedzwiecki Richard M Goldberg Robert J Mayer Karam Ashouri Tyler J Zemla Charles D Blanke Alan P Venook Omar Kabbarah Heinz-Josef Lenz Federico Innocenti
- Networks:
- CA011, CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013
- Study
- Alliance-A152001
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: